1.Relationship of TS mRNA Expression with Therapeutic Efficacy of Pemetrexed in the Treatment of Advanced Breast Cancer
Shourong ZHUO ; Chunxin QIN ; Luyu JIAO ; Jianling YANG ; Hao YU
China Pharmacy 2015;(20):2821-2823
		                        		
		                        			
		                        			OBJECTIVE:To explore the potential correlation between clinical efficacy of pemetrexed in the treatment of ad-vanced breast cancer and TS mRNA expression. METHODS:Patients with advanced breast cancer were recruited in our study. Three cycles of pemetrexed was given to these patients,TS mRNA expression of their tumor tissues were detected. The relationship of ther-apeutic efficacies of different chemotherapy with TS mRNA expression were observed and compared during the study period. RE-SULTS:58 patients received pemetrexed chemotherapy and therapeutic efficacies of them were evaluated. One patient (1.7%) had complete response,19 patients(32.8%)had partial response,31 patients(53.4%)had stable response and 7 patients(12.1%)has progressive disease. Objective response rate was 34.5%,and disease control rate was 87.9%. TS mRNA expression level of 55 pa-tients with completed TS mRNA expression analysis varied from 0.04 to 5.11,with a median of 0.62. Mann-Whitney rank test showed that,responders had lower TS mRNA expression than nonsponders at all visits,there was statistical significance (P<0.05). Chi-square test showed that patients with low expression level of baseline(before chemotherapy)TS mRNA had significantly higher objective response rate(63.3%)than those with high expression(36.7%),there was statistical significance(P<0.05). CON-CLUSIONS:TS mRNA expression level is related to therapeutic efficacy of pemetrexed,which may be useful for predicting thera-peutic efficacy of pemetrexed therapy in patients with advanced breast cancer.
		                        		
		                        		
		                        		
		                        	
2.The Effects XGD-1 on the Proliferation of Human Peripheral Blood T Lymphocyte and the Expression of IL-2R
Li LI ; Shourong ZHUO ;
Chinese Journal of Bases and Clinics in General Surgery 2003;0(03):-
		                        		
		                        			
		                        			Objective  To  explore  the  immunosuppressive  effect  of  XGD  1  and  its  mechanism.  Methods  Different  concentrations  of  XGD  1 were  added  to  PHA  or ConA  induced  human  peripheral  blood  T  lymphocyte.Seventy  two hours  later  modified  MTT  assay  was  employed  to  test  the  effect  of  XGD  1  on  T  cell  proliferation. Flowcytometry  was  used  to  examine  the  effect  of  XGD  1  on  the  expression  of  IL  2  receptor(IL  2R)  on  the  surface  of  T  cells  individually  at  48 h  and  72 h.And  the  effects of XGD  1 combined with cyclosporine A(CsA)  on  the  proliferation  of  T  lymphocytes  and  the  expression  of  IL  2R  were  also  investigated. Results  In  the  concentration  range  of  0.2~25 ?g/ml,XGD  1  exerted  marked  inhibitory  effect  on  PHA  or  ConA  induced  T  cell  proliferation,which  was  proportional  to  dose.  Flowcytometry  showed  that  XGD  1  inhibited  the  expression  of  IL  2R,and  the  percentage  of  IL  2R? positive  cells  after  stimulation  of  PHA  decreased  from  47.67%  to  25.03%  in  the  presence  of  XGD  1 (1 ?g/ml).XGD  1  and  CsA  had  synergism  in  inhibition  of  T  cell  proliferation  and  IL  2R  expression. Conclusion  The  study  suggests  that  XGD  1  has  immunosuppressive  effect. The  suppressive  effect  of  XGD  1  on  T  cell  proliferation  is  most  probably  mediated  by  decreasing  IL  2R  expression.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail